HEMARINA SA expands its operations to Boston U.S.A.

April 23, 2013

Two days into the 2013 BIO International Convention in Chicago, the Massachusetts team is pleased to announce that the French company Hemarina is opening a Boston office – its first in the Americas (please see press release below).

“We enthusiastically welcome Hemarina to the Massachusetts life sciences community,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center, the agency charged with implementing the 10-year, $1-billion Life Sciences Initiative. “According to experts, each year the number of patients waiting to receive organ transplants exceeds the supply, causing the waiting time to increase. By improving the quality of organ preservation, Hemarina’s exciting new HEMO2Life® product will help address this critical imbalance between demand and supply.”

"Today's announcement is a great example of the purpose of our presence at a show like the BIO International Convention-- to showcase the power of collaboration with and among Massachusetts life sciences organizations, companies, and government partners," said Robert K. Coughlin, President & CEO of MassBio. "We are thrilled to welcome Hemarina to Massachusetts and know they will find the clients and partners they seek in our life sciences supercluster."

"Mayor Menino is pleased to welcome biotech innovator Hemarina to Boston," said Boston Redevelopment Authority Director Peter Meade. "This city is a strategic  location for a European company to expand its operations. We look forward to seeing them thrive and grow in Boston's strong life sciences cluster."

 

Hemarina Inc. will be the company affiliate for the Americas

 

Morlaix, France - 04/23/2013 – HEMARINA, the French based Biotechnology Company, today announced its establishment in Boston, Massachusetts USA thru the incorporation of Hemarina Inc. on March 15th, 2013. The new affiliate will be in charge of North and South America and will allow HEMARINA to deploy its global strategy more efficiently, and will be the corporate link between its headquarters located in Morlaix, France to facilitate its partnerships in the Americas.

Seven years after its creation, HEMARINA has decided to accelerate its developments and anticipates the registration of its product HEMO2Life® which is an additive to organ preservation solutions to enhance, and improve organ quality and preservation duration and conditions in the transplantation field.  As one the world’s leading Life Sciences hubs, Boston and Cambridge, has a most flourishing and attractive environment, and therefore is a natural choice for a biotechnology company like HEMARINA.

 

Dr. Franck Zal, Chief Executive Officer and Scientific Executive Officer, HEMARINA commented: “The U.S. pharma and biotech markets tend to be early technology adopters, and Boston is an ideal location for Hemarina Inc. to benefit from this rich innovation ecosystem from a culture and networks perspectives. Furthermore, the new affiliate office is expected to facilitate the administrative and operational processes required for HEMARINA with its scientific and commercial partners in the United States including ongoing collaborations such as with the Naval Medical Research Center (NMRC) and Naval Medical Research Unit of San Antonio (NAMRU-SA).”

The affiliate has been organized in collaboration with the law firm of Morse, Barnes-Brown & Pendleton, and ITRA Global The Stevens Group. Morse, Barnes-Brown & Pendleton will continue to act as legal counsel for Hemarina Inc. in its operations. The offices of Hemarina Inc. will be located in Ten Post Office Square, 8th Floor Boston, MA 02109.

 

About HEMARINA:

HEMARINA is a biotechnology start-up based in Morlaix, France; developing innovative solutions for patients and healthcare industry based on its universal oxygen carriers portfolio and pipeline products. HEMARINA has four core business programs, all of which are patented breakthrough innovations: organ transplantation and tissue conservation, blood substitutes, infections and wound healing, and bio-production. HEMARINA’s core assets and know-how are based on marine molecules, and its corporate culture, policy and social responsibility are based on a focus on large unmet medical needs, a public health issues-solving mindset, excellence in science and processes, and nature conservation and environment friendly approaches and attitudes.

For more information about HEMARINA, please visit www.HEMARINA.com

 

About Morse, Barnes-Brown & Pendleton:

Morse, Barnes-Brown & Pendleton focuses exclusively on the core legal services that businesses need to succeed. The firm is built on a unique business model that provides its clients with access to highly experienced counsel in the areas of corporate and corporate finance law; intellectual property; licensing and strategic alliances; employment and immigration; and tax planning and defense. While it enjoys a reputation for special competency in life sciences and other technology ventures, it represents clients in all industries and of all sizes – from startups to Fortune 1000 companies.

For more information about Morse, Barnes-Brown & Pendleton, please visit www.mbbp.com

 

About ITRA Global | The Stevens Group:

The Stevens Group was founded in 1980 to provide commercial real estate services to corporate clients, assisting them in the leasing, acquisition and disposition of commercial real estate.  The Stevens Group’s mission is to provide its clients with the most complete, unbiased real estate advice and the most efficient systems in business real estate, combining international reach and local knowledge to obtain the best possible space at the best possible terms.

For more information about ITRA Global The Stevens Group, please visit www.thestevensgrp.com/

 

Contacts:

For HEMARINA & Hemarina Inc:

Phone: +33 298 880 360

E-mail: media@HEMARINA.com

Website: www.hemarina.com

Twitter: @HEMARINA

Facebook: HemarinaBiotech

For MBBP:

Phone: +1-781-697-2223

E-mail: pbarnes-brown@mbbp.com

Website: www.mbbp.com

For Stevens Group:

Phone: +1-617-886-9300

E-mail: dstevens@thestevensgrp.com

Website: www.thestevensgrp.com

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.